These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19147272)

  • 1. Editorial comment on: Observation should be considered as an alternative in management of renal masses in older and comorbid patients.
    Volpe A
    Eur Urol; 2009 Jun; 55(6):1428-9. PubMed ID: 19147272
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial comment on: Observation should be considered as an alternative in management of renal masses in older and comorbid patients.
    Remzi M
    Eur Urol; 2009 Jun; 55(6):1427-8. PubMed ID: 19147268
    [No Abstract]   [Full Text] [Related]  

  • 3. Observation should be considered as an alternative in management of renal masses in older and comorbid patients.
    Beisland C; Hjelle KM; Reisaeter LA; Bostad L
    Eur Urol; 2009 Jun; 55(6):1419-27. PubMed ID: 19147267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editorial comment on: Impact of C-reactive protein kinetics on survival of patients with metastatic renal cell carcinoma.
    Novara G
    Eur Urol; 2009 May; 55(5):1153-4. PubMed ID: 18930580
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
    Bertini R; Roscigno M; Freschi M; Strada E; Petralia G; Pasta A; Matloob R; Sozzi F; Da Pozzo L; Colombo R; Guazzoni G; Doglioni C; Montorsi F; Rigatti P
    J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active surveillance of renal masses in elderly patients.
    Abouassaly R; Lane BR; Novick AC
    J Urol; 2008 Aug; 180(2):505-8; discussion 508-9. PubMed ID: 18550113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal cell carcinoma: urologists in a new era.
    Uzzo RG
    J Urol; 2005 Nov; 174(5):1723-4. PubMed ID: 16217270
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial comment on: Collecting duct renal cell carcinoma: a matched analysis of 41 cases.
    van der Kwast TH
    Eur Urol; 2007 Oct; 52(4):1146. PubMed ID: 17336448
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial comment on: Collecting duct renal cell carcinoma: a matched analysis of 41 cases.
    Pantuck AJ
    Eur Urol; 2007 Oct; 52(4):1145-6. PubMed ID: 17336450
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial comment on: impact of gender in renal cell carcinoma: an analysis of the SEER database.
    Patard JJ
    Eur Urol; 2008 Jul; 54(1):141-2. PubMed ID: 18160206
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial comment on: impact of gender in renal cell carcinoma: an analysis of the SEER database.
    Murai M
    Eur Urol; 2008 Jul; 54(1):140-1. PubMed ID: 18160208
    [No Abstract]   [Full Text] [Related]  

  • 12. The natural history of small renal masses.
    Volpe A; Jewett MA
    Nat Clin Pract Urol; 2005 Aug; 2(8):384-90. PubMed ID: 16474735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial comment on: Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Kirkali Z
    Eur Urol; 2009 Feb; 55(2):460. PubMed ID: 18692949
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial comment on: Vaccine therapy in patients with renal cell carcinoma.
    Bellmunt J; Ribas A
    Eur Urol; 2009 Jun; 55(6):1342-3. PubMed ID: 19201525
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic factors in renal cell cancer.
    Park WH; Eisen T
    BJU Int; 2007 May; 99(5 Pt B):1277-81. PubMed ID: 17441924
    [No Abstract]   [Full Text] [Related]  

  • 16. Kidney cancer in the elderly.
    Kirkali Z
    Urol Oncol; 2009; 27(6):673-6. PubMed ID: 19879478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of comorbidity in competing risks analysis in patients with localized renal cell carcinoma.
    Lagro J; Melis RJ; Olde Rikkert MG
    J Clin Oncol; 2010 Jun; 28(18):e298; author reply e301. PubMed ID: 20479414
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of adjuvant interferon-alpha therapy following curative resection in renal cell carcinoma: before the molecular targeting therapy era.
    Kai F; Takayama T; Sugiyama T; Furuse H; Mugiya S; Ozono S
    Jpn J Clin Oncol; 2009 May; 39(5):310-4. PubMed ID: 19363055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial comment.
    Russo P
    Urology; 2009 May; 73(5):1082. PubMed ID: 19394510
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial Comment on: Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas.
    Staehler M
    Eur Urol; 2007 Oct; 52(4):1155. PubMed ID: 17287072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.